Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab.
| Image |  |
|---|---|
| Description | scientific article published on 2 June 2008 |
| Author/s |
author: Mark Bishton Rodney J. Hicks |
| Publication date | June 2, 2008 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |